Novartis AG

Gait features for discriminating between mobility-limiting musculoskeletal disorders: Lumbar spinal stenosis and knee osteoarthritis (2020) Odonkor C, Kuwabara A, Tomkins-Lane C, Zhang W, Muaremi A, Leutheuser H, Sun R, Smuck M Journal article SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL (2020) Baraliakos X, Gossec L, Pournara E, Jeka S, Blanco R, D'Angelo S, Schett G, et al. Conference contribution Mode of action-based risk assessment of genotoxic carcinogens (2020) Hartwig A, Arand M, Epe B, Guth S, Jahnke G, Lampen A, Martus HJ, et al. Journal article, Review article Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) plus fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3) (2020) Fasching P, Neven P, Jerusalem G, Beck JT, Chan A, De Laurentiis M, Bianchi GV, et al. Conference contribution Quality-adjusted survival with ribociclib plus fulvestrant (R plus F) versus placebo plus fulvestrant (P plus F) in postmenopausal women (PMW) HR+/HER2-advanced breast cancer (ABC) based on the MONALEESA-3 trial (2020) Jerusalem G, Delea T, Martin Jimenez M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Conference contribution Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study (2020) McInnes IB, Mease PJ, Kivitz AJ, Nash P, Rahman P, Rech J, Conaghan PG, et al. Journal article Measurement of Skeletal Muscle Fiber Contractility with High-Speed Traction Microscopy (2020) Böhringer D, Rausch M, Steinmann M, Schrüfer S, Schubert DW, Haertl A, Mark C, Fabry B Conference contribution Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer (2020) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Journal article Psoriasis Patients are still severely underserved: Results of the DERMLINE Online Survey (2020) Hell K, Schielein MC, Romer K, Hacker E, Baeumer D, Wagner N, Zink A Conference contribution Patients with Chronic Urticaria need better Treatment: Results of the DERMLINE Online Survey (2020) Hell K, Zink A, Schielein MC, Hacker E, Romer K, Baeumer D, Wagner N Conference contribution